![Seth Fischer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 441 402 $ in data 31/05/2026
Mr. Seth H.
Fischer is an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc., an Independent Director at Esperion Therapeutics, Inc. and an Advisor at Healthquest Capital Management Co LLC.
He is on the Board of Directors at Milestone Pharmaceuticals, Inc. and Esperion Therapeutics, Inc. Mr. Fischer was previously employed as an Independent Director by Marinus Pharmaceuticals, Inc., a Lead Independent Director by Agile Therapeutics, Inc., a Chief Executive Officer & Director by VIVUS, Inc., a Group Chairman by Biosense Webster, Inc., a Chairman-Worldwide Franchise by Cordis Corp., a Group Chairman by North American Pharmaceuticals Co., a Chairman & President by Ortho-McNeil Pharmaceutical, Inc., a Group Chairman by Johnson & Johnson, a Chairman by Janssen Pharmaceuticals, Inc., and a Chairman by Scios, Inc. He also served on the board at Spectrum Pharmaceuticals, Inc., BioSig Technologies, Inc. and Trius Therapeutics, Inc. He received his undergraduate degree from The Ohio University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/05/2026 | 141.023 ( 0,05% ) | 441 402 $ | 31/05/2026 | |
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 28/10/2021 |
| MILESTONE PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 21/03/2023 |
Healthquest Capital Management Co LLC
 Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital invests in companies located in the United States. The firm focuses on services, healthcare IT, medical devices, diagnostics and pharma services. It participates in growth stage transactions with an investment size of USD 20 - 100 million. The firm also makes co-investments and acts as a lead investor. | Consulente / Consigliere | - |
| Società | Posizione | Fine |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 11/02/2025 |
| AGILE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 26/08/2024 |
| SPECTRUM PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 31/07/2023 |
| STREAMEX CORP. | Direttore/Membro del Consiglio | 17/05/2019 |
| VIVUS, INC. | Amministratore Delegato | 31/12/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 17 |
|---|---|
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Develops and manufactures high-quality cardiovascular & endovascular medical devices | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes next-generation therapies | Health Technology |
Spectrum Pharmaceuticals, Inc.
 Spectrum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel and targeted oncology & hematology drug products | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Agile Therapeutics, Inc.
 Agile Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures hormonal contraceptive products | Health Technology |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
BioSig Technologies, Inc.
 BioSig Technologies, Inc. Investment Banks/BrokersFinance Operates as an asset tokenization company that provides blockchain technology to tokenize gold and commodities | Finance |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biosense Webster, Inc.
 Biosense Webster, Inc. Medical SpecialtiesHealth Technology Provides diagnostic and therapeutic catheters | Health Technology |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
North American Pharmaceuticals Co. | |
Healthquest Capital Management Co LLC
Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital invests in companies located in the United States. The firm focuses on services, healthcare IT, medical devices, diagnostics and pharma services. It participates in growth stage transactions with an investment size of USD 20 - 100 million. The firm also makes co-investments and acts as a lead investor. | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
